OTC deals hit an unprecedented high

25 March 2015 - Deborah Wilkes

Archived

Opportunities to acquire leading OTC players have generally been few and far between over the past 20 years. But that all changed in 2014, when Novartis’ OTC business, Merck & Co’s Consumer Care business and Belgian OTC specialist Omega Pharma came up for grabs.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: